Posted by ABMN Staff on Mar 29th, 2024
UBS Group assumed coverage on shares of enGene (NASDAQ:ENGN – Free Report) in a research note published on Thursday morning, Marketbeat reports. The firm issued a buy rating and a $37.00 target price on the stock.
Several other...
More of this article »